SHL Medical discusses the evolution of drug formulations and how it’s supporting cartridge-based subcutaneous drug delivery in redefining the field of patient self-injection.
Andrew Lee, senior consultant at lab services and consultancy specialist, Broughton, reports that packaging selection is an important consideration for many drug products, particularly pressurised metered dose inhalers (pMDIs).
Kerstin Pohl, sr. global manager, Gene Therapies, at SCIEX, and Thomas Kofoed, co-founder of Alphalyse, discussed the harmful effects of HCPs and strategies to mitigate them.
Michael Earl, director, pharmaceutical services at Owen Mumford, examines the benefits that patients are set to receive as the connected drug delivery devices market grows.
Dr. Jan Ehlers, chief executive officer at Secop GmbH, shares the trends and challenges in the cold chain industry and the rising demand for vaccine transport solutions.
Matt Watson, European Manufacturing Sector expert at Aggreko Europe, is highlighting the importance of looking into other technologies to help maintain power baseloads at a challenging time for the industry.
As CARBOGEN AMCIS opens its doors to a new sterile liquid drug product manufacturing facility in France, EPM caught up with Pascal Villemagne, CEO of CARBOGEN AMCIS, to discuss what this will mean for CARBOGEN's capabilities in freeze-dried products.
Penelope Drake, Ph.D., head of R&D, Bioconjugates, Catalent, highlights the potential of anti-body-drug conjugates in paving a way to innovation in oncology treatments.
Timothy Korwan, director, new product introductions, Avantor, describes how using a dedicated training room can ensure the reliability and quality of single-use (SU) systems.
Adam Clore, director of development & innovation at Integrated DNA Technologies, shares the achievements and objectives of mRNA vaccines; from the 1990s to the COVID-19 pandemic, and the hopes for the future.
Christian Marcazzo, vice president/general manager of IDBS discusses how cloud-based solutions can create seamless communication between innovators and CDMOs.
With the ongoing energy crisis, Rebekah Jordan considers the effect of surging manufacturing costs on the pharma sector in Europe, and pharma's hopes to mitigate production and supply chain issues with resiliency and innovation.
